|
OMIM |
Link |
Information gain |
01 |
|
KLK3
|
[NCBI]
|
0.00053971
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000188994
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
8.20504e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
7.22139e-05
|
|
|
EFE
|
[NCBI]
|
6.95065e-05
|
|
|
OPTB1
|
[NCBI]
|
6.71283e-05
|
|
|
CEACAM5
|
[NCBI]
|
5.80692e-05
|
|
|
FMF
|
[NCBI]
|
5.20897e-05
|
|
|
AVSD
|
[NCBI]
|
4.87949e-05
|
|
|
RA
|
[NCBI]
|
4.1056e-05
|
|
|
CSPG4
|
[NCBI]
|
3.20928e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
3.20509e-05
|
|
|
GIST
|
[NCBI]
|
2.88312e-05
|
|
|
PGR
|
[NCBI]
|
2.36895e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.04847e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
2.00039e-05
|
|
|
RP2
|
[NCBI]
|
1.98416e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.67425e-05
|
|
|
IFNA1
|
[NCBI]
|
1.52345e-05
|
|
|
AFP
|
[NCBI]
|
1.50459e-05
|
|
|
TPMT
|
[NCBI]
|
1.47474e-05
|
|
|
BRCA2
|
[NCBI]
|
1.41717e-05
|
|
|
ABCB1
|
[NCBI]
|
1.35366e-05
|
|
|
BRCA1
|
[NCBI]
|
1.1054e-05
|
|
|
RB1
|
[NCBI]
|
1.09603e-05
|
|
|
ACPP
|
[NCBI]
|
1.05799e-05
|
|
|
PCNA
|
[NCBI]
|
8.74964e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
6.27105e-06
|
|
|
HD
|
[NCBI]
|
5.7579e-06
|
|
|
EGF
|
[NCBI]
|
4.12503e-06
|
|
|
MG
|
[NCBI]
|
3.41473e-06
|
|
|
TNF
|
[NCBI]
|
3.23474e-06
|
|
|
VEGF
|
[NCBI]
|
3.19537e-06
|
|
|
EGFR
|
[NCBI]
|
1.77446e-06
|
|
|
SLE
|
[NCBI]
|
4.31372e-07
|
|
|
PRL
|
[NCBI]
|
1.95881e-07
|
|
|
EPO
|
[NCBI]
|
1.39758e-07
|
|
|
CF
|
[NCBI]
|
1.28756e-07
|
|
|
CRC
|
[NCBI]
|
1.10596e-07
|
|